Fleischmann, C., Scherag, A., Adhikari, N. K., Hartog, C. S., Tsaganos, T., Schlattmann, P., et al. (2016). Assessment of global incidence and mortality of Hospital-treated sepsis. Current Estimates and Limitations American Journal of Respiratory and Critical Care Medicine, 193(3), 259–272.
Fleischmann-Struzek, C., Mellhammar, L., Rose, N., Cassini, A., Rudd, K., Schlattmann, P., et al. (2020). Incidence and mortality of hospital-and ICU-treated sepsis: Results from an updated and expanded systematic review and meta-analysis. Intensive Care Medicine, 46, 1552–1562.
CAS PubMed PubMed Central Google Scholar
Abdulmalek, O. A. A. Y., Husain, K. H., AlKhalifa, H. K. A. A., Alturani, M. M. A. B., Butler, A. E., & Moin, A. S. M. (2024). Therapeutic applications of stem Cell-Derived exosomes. International Journal of Molecular Sciences, 25(6), 3562.
CAS PubMed PubMed Central Google Scholar
Piccioni, A., Spagnuolo, F., Candelli, M., Voza, A., Covino, M., Gasbarrini, A., et al. (2024). The gut Microbiome in sepsis: From dysbiosis to personalized therapy. Journal of Clinical Medicine, 13(20), 6082.
CAS PubMed PubMed Central Google Scholar
Gatt, M. (2015). The role of the gut in sepsis. Surgery (Oxford), 33(11)(01/), 534–541. 2015/11/.
Chen, G., Huang, B., Fu, S., Li, B., Ran, X., He, D., et al. (2018). G Protein-Coupled receptor 109A and host microbiota modulate intestinal epithelial integrity during sepsis. Frontiers in Immunology, 9, 2079.
PubMed PubMed Central Google Scholar
Yoseph, B. P., Klingensmith, N. J., Liang, Z., Breed, E. R., Burd, E. M., Mittal, R., et al. (2016). Mechanisms of intestinal barrier dysfunction in sepsis. Shock (Augusta Ga), 46(1), 52–59.
Dominguez, J. A., Vithayathil, P. J., Khailova, L., Lawrance, C. P., Samocha, A. J., Jung, E., et al. (2011). Epidermal growth factor improves survival and prevents intestinal injury in a murine model of Pseudomonas aeruginosa pneumonia. Shock (Augusta Ga), 36(4), 381–389.
Zhang, Y., Liu, Y., Xie, Z., Liu, Q., Zhuang, Y., Xie, W. (2022). Inhibition of PFKFB preserves intestinal barrier function in sepsis by inhibiting NLRP3/GSDMD. Oxidative Medicine and Cellular Longevity.;2022:8704016.
Neal, M. D., Leaphart, C., Levy, R., Prince, J., Billiar, T. R., Watkins, S. (1950). Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. Journal of Immunology (Baltimore, Md: 2006;176(5):3070-9.
Wang, Y. (2020). The effects and mechanism of bone marrow mesenchymal stem cells exosomes on intestinal barrier function in sepsis rates.
Mainous, M. R., Ertel, W., Chaudry, I. H., & Deitch, E. A. (1995). The gut: A cytokine-generating organ in systemic inflammation? Shock (Augusta. Ga), 4(3), 193–199.
Friedenstein, A. J., Piatetzky, S., & II, Petrakova, K. V. (1966). Osteogenesis in transplants of bone marrow cells. Journal of Embryology and Experimental Morphology, 16(3), 381–390.
Yaghoubi, Y., Movassaghpour, A., Zamani, M., Talebi, M., Mehdizadeh, A., & Yousefi, M. (2019). Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment. Life Sciences, 233, 116733.
Liu, C., Xue, J., Xu, B., Zhang, A., Qin, L., Liu, J., et al. (2021). Exosomes derived from miR-146a‐5p‐Enriched mesenchymal stem cells protect the cardiomyocytes and myocardial tissues in the polymicrobial sepsis through regulating MYBL1. Stem Cells International, 2021(1), 1530445.
PubMed PubMed Central Google Scholar
Li, J., Deng, X., Ji, X., Shi, X., Ying, Z., Shen, K., et al. (2020). Mesenchymal stem cell exosomes reverse acute lung injury through Nrf-2/ARE and NF-κB signaling pathways. PeerJ, 8, e9928.
PubMed PubMed Central Google Scholar
Cai, J., Tang, D., Hao, X., Liu, E., Li, W., & Shi, J. (2023). Mesenchymal stem cell-derived exosome alleviates sepsis-associated acute liver injury by suppressing MALAT1 through microRNA-26a-5p: An innovative Immunopharmacological intervention And therapeutic approach for sepsis. Frontiers in Immunology, 14, 1157793.
CAS PubMed PubMed Central Google Scholar
Li, S., Lv, D., Yang, H., Lu, Y., & Jia, Y. (2023). A review on the current literature regarding the value of exosome MiRNAs in various diseases. Annals of Medicine, 55(1), 2232993.
PubMed PubMed Central Google Scholar
Shang, L., Li, J., Zhou, F., Zhang, M., Wang, S., & Yang, S. (2023). MiR-874-5p targets VDR/NLRP3 to reduce intestinal pyroptosis and improve intestinal barrier damage in sepsis. International Immunopharmacology, 121, 110424.
Cheng, L., Feng, B., Xie, C., Chen, C., & Guo, L. (2025). Overexpression of miR-20a targeting DUSP3 inhibits OCLN ubiquitination levels and alleviates sepsis induced intestinal barrier dysfunction. In Vitro Cellular & Developmental Biology Animal, 61(4), 459–471.
Chang, Y., Huang, Z., Hou, F., Liu, Y., Wang, L., Wang, Z., et al. (2023). Parvimonas Micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression. Journal of Experimental & Clinical Cancer Research: CR, 42(1), 13.
CAS PubMed Central Google Scholar
Ma, X., Zhang, H., Yin, H., Geng, S., Liu, Y., Liu, C., et al. (2021). Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with parkinson’s disease via suppression of LASP1. Brain Research Bulletin, 166, 92–101.
Zhu, H., Wang, X., & Chen, S. (2020). Downregulation of MiR-218-5p protects against Oxygen-Glucose Deprivation/Reperfusion-Induced injuries of PC12 cells via upregulating N-myc downstream regulated gene 4 (NDRG4). Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 26, e920101.
Yang, Y., Zhao, F., Yuan, Z., Wang, C., Chen, K., & Xiao, W. (2021). Inhibition of miR-218-5p reduces myocardial ischemia-reperfusion injury in a Sprague-Dawley rat model by reducing oxidative stress and inflammation through MEF2C/NF-κB pathway. International Immunopharmacology, 101(Pt B), 108299.
Hu, L., Luo, D., Zhang, H., & He, L. (2023). Nardosinone suppresses monoiodoacetate-induced osteoarthritis in rats: The key role of the miR-218-5p/NUMB axis. Chemical Biology & Drug Design, 101(1), 120–130.
Zhang, T., & Xiang, L. (2019). Honokiol alleviates sepsis-induced acute kidney injury in mice by targeting the miR-218-5p/heme oxygenase-1 signaling pathway. Cellular & Molecular Biology Letters, 24, 15.
Liu, Y., Li, Y. P., Xiao, L. M., Chen, L. K., Zheng, S. Y., Zeng, E. M., et al. (2023). Extracellular vesicles derived from bone mesenchymal stem cells carrying circ_0000075 relieves cerebral ischemic injury by competitively inhibiting miR-218-5p and Up-regulating E3 ubiquitin ligase SMURF2. Molecular Neurobiology, 60(5), 2801–2818.
Rager, T. M., Olson, J. K., Zhou, Y., Wang, Y., & Besner, G. E. (2016). Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing Enterocolitis. Journal of Pediatric Surgery, 51(6), 942–947.
PubMed PubMed Central Google Scholar
Yu, H., Yang, X., Xiao, X., Xu, M., Yang, Y., Xue, C., et al. (2021). Human adipose mesenchymal stem Cell-derived exosomes protect mice from DSS-Induced inflammatory bowel disease by promoting Intestinal-stem-cell and epithelial regeneration. Aging and Disease, 12(6), 1423–1437.
PubMed PubMed Central Google Scholar
Mao, F., Wu, Y., Tang, X., Kang, J., Zhang, B., Yan, Y., et al. (2017). Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice. BioMed Research International, 2017, 5356760.
PubMed PubMed Central Google Scholar
Yang, S., Liang, X., Song, J., Li, C., Liu, A., Luo, Y., et al. (2021). A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6. Stem Cell Research & Therapy, 12(1), 315.
Sun, Z., Gu, P., Xu, H., Zhao, W., Zhou, Y., Zhou, L., et al. (2022). Human umbilical cord mesenchymal stem cells improve locomotor function in parkinson’s disease mouse model through regulating intestinal microorganisms. Frontiers in Cell and Developmental Biology, 9, 808905.
PubMed PubMed Central Google Scholar
Liang, X. J., Chen, X. J., Yang, D. H., Huang, S. M., Sun, G. D., & Chen, Y. P. (2012). Differentiation of human umbilical cord mesenchymal stem cells into hepatocyte-like cells by hTERT gene transfection in vitro. Cell Biology International, 36(2), 215–221.
Li, Z., Qin, X., Bian, W., Li, Y., Shan, B., Yao, Z., et al. (2019). Exosomal LncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis. Journal of Experimental & Clinical Cancer Research, 38, 1–13.
Xu, Y., Zhang, X., Tang, X., Zhang, C., Cahoon, J. G., Wang, Y., et al. (2024). Dexmedetomidine post-treatment exacerbates metabolic disturbances in septic cardiomyopathy via α(2A)-adrenoceptor (Vol. 170, p. 115993). Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Filipowicz, W., Bhattacharyya, S. N., & Sonenberg, N. (2008). Mechanisms of post-transcriptional regulation by micrornas: Are the answers in sight? Nature Reviews Genetics, 9(2), 102–114.
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., et al. (2016). The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama, 315(8), 801–810.
CAS PubMed PubMed Central Google Scholar
Plaeke, P., De Man, J. G., Smet, A., Malhotra-Kumar, S., Pintelon, I., Timmermans, J. P., et al. (2020). Effects of intestinal alkaline phosphatase on intestinal barrier function in a cecal ligation and puncture (CLP)-induced mouse model for sepsis. Neurogastroenterology and Motility, 32(3), e13754.
Liu, W., Wang, X. H., Yang, X. J., Zhang, X. Y., & Qi, W. J. (2016). [Intestinal barrier dysfunction and its related factors in patients with sepsis]. Zhonghua Yi Xue Za Zhi, 96(44), 3568–3572.
Comments (0)